News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,148 Results
Type
Article (41643)
Company Profile (263)
Press Release (673225)
Multimedia
Podcasts (116)
Webinars (22)
Section
Business (205630)
Career Advice (2096)
Deals (35609)
Drug Delivery (103)
Drug Development (81424)
Employer Resources (189)
FDA (16357)
Job Trends (14995)
News (347505)
Policy (32769)
Tag
Academia (2624)
Accelerated approval (14)
Adcomms (24)
Allergies (108)
Alliances (49985)
ALS (125)
Alzheimer's disease (1530)
Antibody-drug conjugate (ADC) (171)
Approvals (16404)
Artificial intelligence (389)
Autoimmune disease (40)
Automation (23)
Bankruptcy (363)
Best Places to Work (11705)
BIOSECURE Act (19)
Biosimilars (133)
Biotechnology (181)
Bladder cancer (111)
Brain cancer (39)
Breast cancer (411)
Cancer (3311)
Cardiovascular disease (266)
Career advice (1761)
Career pathing (35)
CAR-T (204)
CDC (37)
Cell therapy (550)
Cervical cancer (27)
Clinical research (67585)
Collaboration (1198)
Company closure (4)
Compensation (836)
Complete response letters (36)
COVID-19 (2675)
CRISPR (67)
C-suite (479)
Cystic fibrosis (123)
Data (3693)
Decentralized trials (2)
Denatured (58)
Depression (80)
Diabetes (387)
Diagnostics (6581)
Digital health (28)
Diversity (11)
Diversity, equity & inclusion (47)
Drug discovery (171)
Drug pricing (139)
Drug shortages (29)
Duchenne muscular dystrophy (171)
Earnings (88750)
Editorial (45)
Employer branding (24)
Employer resources (158)
Events (115478)
Executive appointments (905)
FDA (18502)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1050)
Gene editing (147)
Generative AI (28)
Gene therapy (438)
GLP-1 (839)
Government (4591)
Grass and pollen (5)
Guidances (331)
Healthcare (19033)
HIV (43)
Huntington's disease (31)
IgA nephropathy (47)
Immunology and inflammation (182)
Immuno-oncology (13)
Indications (45)
Infectious disease (2867)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (77)
Intellectual property (156)
Interviews (334)
IPO (16666)
IRA (51)
Job creations (3652)
Job search strategy (1475)
Kidney cancer (13)
Labor market (69)
Layoffs (526)
Leadership (29)
Legal (7945)
Liver cancer (84)
Longevity (12)
Lung cancer (478)
Lymphoma (243)
Machine learning (23)
Management (61)
Manufacturing (505)
MASH (107)
Medical device (13672)
Medtech (13689)
Mergers & acquisitions (19744)
Metabolic disorders (946)
Multiple sclerosis (112)
NASH (16)
Neurodegenerative disease (152)
Neuropsychiatric disorders (38)
Neuroscience (2337)
NextGen: Class of 2025 (6592)
Non-profit (4542)
Now hiring (54)
Obesity (462)
Opinion (240)
Ovarian cancer (111)
Pain (137)
Pancreatic cancer (141)
Parkinson's disease (198)
Partnered (24)
Patents (364)
Patient recruitment (261)
Peanut (52)
People (58509)
Pharmaceutical (62)
Pharmacy benefit managers (21)
Phase I (21033)
Phase II (29772)
Phase III (22138)
Pipeline (2384)
Policy (238)
Postmarket research (2572)
Preclinical (8967)
Press Release (66)
Prostate cancer (162)
Psychedelics (39)
Radiopharmaceuticals (257)
Rare diseases (524)
Real estate (5941)
Recruiting (70)
Regulatory (23200)
Reports (64)
Research institute (2394)
Resumes & cover letters (358)
Rett syndrome (11)
RNA editing (13)
RSV (55)
Schizophrenia (106)
Series A (173)
Series B (130)
Service/supplier (11)
Sickle cell disease (68)
Special edition (21)
Spinal muscular atrophy (148)
Sponsored (36)
Startups (3629)
State (2)
Stomach cancer (14)
Supply chain (86)
Tariffs (72)
The Weekly (56)
Vaccines (866)
Venture capital (59)
Weight loss (291)
Women's health (56)
Worklife (20)
Date
Today (106)
Last 7 days (429)
Last 30 days (2249)
Last 365 days (31255)
2025 (21850)
2024 (35542)
2023 (40382)
2022 (51455)
2021 (56039)
2020 (54459)
2019 (47023)
2018 (35358)
2017 (32381)
2016 (31749)
2015 (37814)
2014 (31531)
2013 (26605)
2012 (28821)
2011 (29464)
2010 (27522)
Location
Africa (734)
Alabama (70)
Alaska (7)
Arizona (260)
Arkansas (14)
Asia (38732)
Australia (6331)
California (8570)
Canada (2646)
China (777)
Colorado (358)
Connecticut (370)
Delaware (224)
Europe (83970)
Florida (1276)
Georgia (287)
Hawaii (2)
Idaho (60)
Illinois (684)
India (38)
Indiana (404)
Iowa (17)
Japan (260)
Kansas (114)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1142)
Massachusetts (6267)
Michigan (264)
Minnesota (506)
Mississippi (4)
Missouri (101)
Montana (29)
Nebraska (25)
Nevada (98)
New Hampshire (68)
New Jersey (2340)
New Mexico (28)
New York (2332)
North Carolina (1219)
North Dakota (8)
Northern California (3870)
Ohio (264)
Oklahoma (16)
Oregon (38)
Pennsylvania (1805)
Puerto Rico (17)
Rhode Island (41)
South America (1108)
South Carolina (43)
South Dakota (1)
Southern California (3299)
Tennessee (138)
Texas (1323)
United States (31239)
Utah (255)
Virginia (213)
Washington D.C. (74)
Washington State (712)
West Virginia (4)
Wisconsin (71)
715,148 Results for "magnetic insight inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH TRUVETA
Webinar: AI for Faster, More Precise Real-World Research: Extracting Clinical Notes Data at Scale
In this webinar, we’ll explore how the Truveta Language Model (TLM)—a multi-modal AI model trained on EHR data—unlocks insights from clinical notes at scale. Watch now.
August 27, 2025
·
1 min read
·
BioSpace Insights
THOUGHT LEADERSHIP
Webinar: Driving Biopharma Engagement: How Thought Leadership and Marketing Fuel Lead Generation
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. This webinar will show leaders how strategic insights and targeted outreach can turn awareness into high-converting leads. Watch now.
September 10, 2025
·
1 min read
·
BioSpace Insights
Employer Resources
Report: Driving Biopharma Engagement
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
August 11, 2025
·
1 min read
·
BioSpace Insights
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH TACONIC BIOSCIENCES
The ‘Research Safety Net’ Saving Scientists from Funding Crisis
In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research companies are helping drug developers navigate the current challenging funding environment with Mike Garrett, CEO.
September 4, 2025
·
1 min read
·
Lori Ellis
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
In this episode of Denatured, BioSpace’s head of insights Lori Ellis discusses the ‘enormous implications’ of patent policy changes with Aaron Cummings and Anne Li of Brownstein Hyatt Farber Schreck.
August 14, 2025
·
1 min read
·
Lori Ellis
Press Releases
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 17, 2025
·
8 min read
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH IQVIA
We Don’t Own Patient Data–We’re Just Babysitting It
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.
July 31, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.
August 21, 2025
·
1 min read
·
Lori Ellis
1 of 71,515
Next
